<?xml version="1.0" encoding="UTF-8"?>
<fig id="F2" orientation="portrait" position="float">
 <label>FIGURE 2</label>
 <caption>
  <p>Proposed mechanism of action of drugs used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 can enter the cell through angiotensin-converting enzyme 2 (ACE2) and type II transmembrane serine protease (TMPRSS2). Camostat mesylate acts as an inhibitor of TMPRSS2 and umifenovir can inhibit the viral entry to the cell [
   <xref rid="C180" ref-type="bibr">180</xref>, 
   <xref rid="C228" ref-type="bibr">228</xref>, 
   <xref rid="C229" ref-type="bibr">229</xref>]. Chloroquine, hydroxychloroquine and baricitinib mechanisms of action are not fully understood; however, it is proposed that these drugs affect viral entry. Baricitinib also inhibits the AP-2-associated protein kinase [
   <xref rid="C173" ref-type="bibr">173</xref>, 
   <xref rid="C180" ref-type="bibr">180</xref>, 
   <xref rid="C230" ref-type="bibr">230</xref>]. Lopinavir/ritonavir and ASC-09/ritonavir as protease inhibitors inhibit the proteolysis. Lopinavir/ritonavir inhibits specifically the proteinase 3CLpro [
   <xref rid="C231" ref-type="bibr">231</xref>]. Ribavirin and favipiravir both have wide antiviral activity and have the potential to inhibit SARS-CoV-2 RNA replication [
   <xref rid="C232" ref-type="bibr">232</xref>–
   <xref rid="C234" ref-type="bibr">234</xref>]. Azvudine, a nucleoside reverse transcriptase inhibitor, also inhibits RNA replication [
   <xref rid="C235" ref-type="bibr">235</xref>]. A probable mechanism of action for baloxavir marboxil is the inhibition of transcription through inhibiting cap-dependent endonuclease [
   <xref rid="C236" ref-type="bibr">236</xref>]. Favipiravir and remdesivir inhibit the RNA-dependent RNA polymerase (RdRp), which results in reduced RNA synthesis [
   <xref rid="C180" ref-type="bibr">180</xref>, 
   <xref rid="C233" ref-type="bibr">233</xref>, 
   <xref rid="C234" ref-type="bibr">234</xref>, 
   <xref rid="C237" ref-type="bibr">237</xref>]. Adapted from “Coronavirus Replication Cycle” (2020; 
   <ext-link ext-link-type="uri" xlink:href="https://app.biorender.com/biorender-templates" xmlns:xlink="http://www.w3.org/1999/xlink">https://app.biorender.com/biorender-templates</ext-link>).
  </p>
 </caption>
 <graphic xlink:href="ERJ-01727-2020.02" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
